Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and Screening
Open Access
- 17 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10) , e77697
Abstract
In resource-constrained settings, tuberculosis (TB) is a common opportunistic infection and cause of death in HIV-infected persons. TB may be present at the start of antiretroviral therapy (ART), but it is often under-diagnosed. We describe approaches to TB diagnosis and screening of TB in ART programs in low- and middle-income countries. We surveyed ART programs treating HIV-infected adults in sub-Saharan Africa, Asia and Latin America in 2012 using online questionnaires to collect program-level and patient-level data. Forty-seven sites from 26 countries participated. Patient-level data were collected on 987 adult TB patients from 40 sites (median age 34.7 years; 54% female). Sputum smear microscopy and chest radiograph were available in 47 (100%) sites, TB culture in 44 (94%), and Xpert MTB/RIF in 23 (49%). Xpert MTB/RIF was rarely available in Central Africa and South America. In sites with access to these diagnostics, microscopy was used in 745 (76%) patients diagnosed with TB, culture in 220 (24%), and chest X-ray in 688 (70%) patients. When free of charge culture was done in 27% of patients, compared to 21% when there was a fee (p = 0.033). Corresponding percentages for Xpert MTB/RIF were 26% and 15% of patients (p = 0.001). Screening practices for active disease before starting ART included symptom screening (46 sites, 98%), chest X-ray (38, 81%), sputum microscopy (37, 79%), culture (16, 34%), and Xpert MTB/RIF (5, 11%). Mycobacterial culture was infrequently used despite its availability at most sites, while Xpert MTB/RIF was not generally available. Use of available diagnostics was higher when offered free of charge.Keywords
This publication has 28 references indexed in Scilit:
- The impact of new tuberculosis diagnostics on transmission: why context mattersBulletin of the World Health Organization, 2012
- TB Diagnostic Capacity in Sub-Saharan African HIV Care SettingsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Drug-Resistant Tuberculosis—Current Dilemmas, Unanswered Questions, Challenges, and Priority NeedsThe Journal of Infectious Diseases, 2012
- Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact [Correspondence]The International Journal of Tuberculosis and Lung Disease, 2012
- Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan AfricaInternational Journal of Epidemiology, 2011
- Tuberculosis after Initiation of Antiretroviral Therapy in Low-Income and High-Income CountriesClinical Infectious Diseases, 2007
- Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programmeInternational Journal of Epidemiology, 2007
- Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)International Journal of Epidemiology, 2007
- Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentThe Lancet, 2006
- Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort studyThe Lancet, 2002